Global cardiac pacemaker devices market is expected to grow at a CAGR of 3.3% from 2017 to 2022 to reach USD 4,629.3 million by 2022
The innovative pacemaker delivers the low voltage electrical support to stimulate the heart to beat in a normal synchronized way in patients with bradycardia and heart failure, to help reduce related morbidity and mortality. Thus, the adoption of cardiac pacemaker devices is increasing in the high-risk patients with rising incidence & prevalence of various cardiovascular diseases across the globe.
Here are the top 10 companies operating in Cardiac Pacemaker Devices market-
Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland. The company designs, manufactures, and sales medical devices. The company offers its products under four operating business segments i.e. cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. The cardiac and vascular group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices.
The company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa with its 30 subsidiaries including Medtronic PS Medical, Inc., Medtronic MiniMed, Inc., India and Medtronic Private Ltd.
Boston Scientific Corporation
Founded in 1979 and headquartered in Massachusetts, U.S.; Boston Scientific Corporation operates in developing, manufacturing, and marketing medical devices for use in various interventional medical specialties worldwide. The company operates in to three operating business segments i.e. Cardiovascular, Rhythm Management, and MedSurg. Cardiovascular segment offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems and implantable cardiac resynchronization therapy pacemaker systems used to treat & detect abnormally fast heart rhythms & heart failure.
With the strong distribution network and more than 35 subsidiaries including Cardiac pacemakers, Inc. and Boston Scientific Japan K.K; the company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
BIOTRONIK SE & CO., KG
Founded in 1963 and headquartered in Berlin, Germany; BIOTRONIK SE & CO., KG operates in designing, developing, manufacturing, and marketing cardio and endovascular medical devices in Germany and internationally. The company offers products for bradycardia therapy, including pacemakers, leads, and external devices; tachyarrhythmia therapy, such as ICDs, leads, and external devices; ablation and diagnostic catheters, and temporary pacing for electrophysiology for cardiac resynchronization.
The company also provides coronary drug eluting and self-expanding stent systems, coronary balloon-expandable stent systems, drug releasing balloon catheters, balloon catheters, guide wires, and accessories for coronary and peripheral vascular intervention.
The company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Sorin Group and Cyberonics are merged together to create a new premier global medical technology company LivaNova PLC in February 2015. Founded earlier in 1987 and headquartered in London, U.K.; LivaNova PLC operates in designing, developing, manufacturing, and selling therapeutic solutions worldwide. The company operates through three business segments namely neuromodulation, cardiac surgery, and cardiac rhythm management. The neuromodulation segment designs, develops, and markets vagus nerve stimulation (VNS) therapy system; an implantable device for the treatment of drug-resistant epilepsy and treatment-resistant depression; and transcutaneous VNS devices. Cardiac Rhythm Management segment offers implantable Cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools primarily for electrophysiologists, implanting cardiologists, heart failure specialists, and cardiac surgeons.
With more than 35 subsidiaries including LivaNova Austria GmbH, Cyberonics, Inc., and California Medical Laboratories, Inc.; the company has strong geographical presence in North America, Europe, Asia-pacific, Latin America, and Middle East & Africa.
Founded in 1888 and headquartered in Illinois, U.S.; Abbott Laboratories operates in manufacturing & selling health care products worldwide. The company operates in four business segments namely nutritionals products, diagnostics products, established pharmaceutical products, and vascular products. The vascular segments offer a broad line of coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease that are manufactured, marketed and sold worldwide.
The company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. The company has more than 28 subsidiaries worldwide including St. Jude Medical, LLC. The company provide cardiac rhythm management products such as cardiac pacemaker and CRT-P through one of its subsidiary St. Jude Medical, LLC.
A report into the projected growth of the current Cardiac Pacemaker Devices Market by Meticulous Research® has produced some incredible forecasts for the industry. By 2022, it’s expected to have grown at a CAGR of 3.3%, reaching over $4,629.3 million.
Founded in 1973 and is headquartered in Rubano, Italy; MEDICO S.P.A. operates in production of implantable cardiac devices such as pacemaker and leads and external devices namely programmers, PSA pacing system analyzes and electrodes for invasive and not invasive electrophysiological studies.
The Company has strong geographical presence in Europe. Along with Europe the company also markets its products in Asia-Pacific, Latin America, and North America.
Shree Pacetronix Ltd.
Founded in 1988 and is headquartered in Pithampur, Madhya Pradesh, India; Shree Pacetronix Ltd. operates in manufacturing and selling of different range of implantable & external Cardiac pacemakers and related accessories. The company has only one subsidiary namely Shree Coratomic Limited.
Osypka Medical, Inc.
Founded in 1986 and is headquartered in Berlin, Germany; Osypka Medical, Inc. operates into designing, manufacturing, and sales of cardiac rhythm management products. The company majorly offers hemodynamic monitors, external Cardiac pacemakers, and pacing system analyzer. The Company offers temporary pacemakers under the brand PACE series for the treatment of tachycardia, bradycardiaand ultimately, improving patient outcomes. The Company offer its products under the brand name Cardiotronic in the U.S. The company also operates as the original equipment manufacturer (OEM) for companies such as Osypka AG, Oscor, St. Jude Medical and Medtronic.
The Company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Lepu Medical Group
Founded in 1999 and is headquartered in Beijing, China; Lepu Medical Group operates in high-tech medical device development, production and sales.Lepu Medical Group operates through 7 wholly-owned and joint stock subsidiary companies, including Shanghai Shape Memory Alloy Co., Ltd (SHSMA), Beijing Star Medical Devices Co., Ltd (Star Medical), Beijing Target Medical Technologies, Ltd (Target Medical), Lepu Science & Technology Co., Ltd. (Lepu Technology), Lepu Medical Equipment Co., Ltd (Lepu Equipment), and Shaanxi Qinming Medical Co., Ltd.(Qinming Medical).The Company offers its cardiac pacemaker products through its subsidiary namely Lepu Medical Technology (Beijing) Co., Ltd under bradycardia therapy segment.
The company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle- East & Africa.
Founded in 1963 and is headquartered in Indiana, U.S.; Cook Group operates in five business segment namely medical devices, life sciences, services, property management and resort business. Medical devices are offered by its subsidiary namely Cook medical, Cook advanced technologies, and Cook biotech. Cook medical operates in designing, manufacturing, and distributing minimally invasive medical devices for diagnostic and therapeutic procedures in the U.S. and internationally. The Company offers cardiovascular surgical products such as lead extraction devices. The company also offers its product for electrophysiology, interventional cardiology, and interventional radiology.
The company has strong geographical presence across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The company has 15 subsidiaries namely Cook Medical Incorporated through which it offers various cardiovascular surgical products.
Authoritative Research on the Cardiac Pacemaker Devices Market – Global Opportunity Analysis and Industry Forecast (2017-2022)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more: